Erratum: Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism (Journal of Gastroenterology and Hepatology DOI: 10.1111/j.1440-1746.2006.04190.x)

K. Ariizumi; S. Ohara; T. Koike; Y. Inomata; Katsunori Iijima; H. Sekine; M. Noguchi; K. Sugiyama; Y. Eda; S. Kayaba; M. Kawamura; Toru Shimosegawa

doi:10.1111/j.1440-1746.2006.04760.x

Erratum: Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism (Journal of Gastroenterology and Hepatology DOI: 10.1111/j.1440-1746.2006.04190.x)

K. Ariizumi, S. Ohara, T. Koike, Y. Inomata, Katsunori Iijima, H. Sekine, M. Noguchi, K. Sugiyama, Y. Eda, S. Kayaba, M. Kawamura, Toru Shimosegawa

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Pages (from-to)	1871
Number of pages	1
Journal	Journal of Gastroenterology and Hepatology (Australia)
Volume	21
Issue number	12
DOIs	https://doi.org/10.1111/j.1440-1746.2006.04760.x
Publication status	Published - 2006 Dec
Externally published	Yes

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1111/j.1440-1746.2006.04760.x

Cite this

Ariizumi, K., Ohara, S., Koike, T., Inomata, Y., Iijima, K., Sekine, H., Noguchi, M., Sugiyama, K., Eda, Y., Kayaba, S., Kawamura, M., & Shimosegawa, T. (2006). Erratum: Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism (Journal of Gastroenterology and Hepatology DOI: 10.1111/j.1440-1746.2006.04190.x). Journal of Gastroenterology and Hepatology (Australia), 21(12), 1871. https://doi.org/10.1111/j.1440-1746.2006.04760.x

Erratum : Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism (Journal of Gastroenterology and Hepatology DOI: 10.1111/j.1440-1746.2006.04190.x). / Ariizumi, K.; Ohara, S.; Koike, T.; Inomata, Y.; Iijima, Katsunori; Sekine, H.; Noguchi, M.; Sugiyama, K.; Eda, Y.; Kayaba, S.; Kawamura, M.; Shimosegawa, Toru.

In: Journal of Gastroenterology and Hepatology (Australia), Vol. 21, No. 12, 12.2006, p. 1871.

Research output: Contribution to journal › Comment/debate › peer-review

Ariizumi, K, Ohara, S, Koike, T, Inomata, Y, Iijima, K, Sekine, H, Noguchi, M, Sugiyama, K, Eda, Y, Kayaba, S, Kawamura, M & Shimosegawa, T 2006, 'Erratum: Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism (Journal of Gastroenterology and Hepatology DOI: 10.1111/j.1440-1746.2006.04190.x)', Journal of Gastroenterology and Hepatology (Australia), vol. 21, no. 12, pp. 1871. https://doi.org/10.1111/j.1440-1746.2006.04760.x

Ariizumi K, Ohara S, Koike T, Inomata Y, Iijima K, Sekine H et al. Erratum: Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism (Journal of Gastroenterology and Hepatology DOI: 10.1111/j.1440-1746.2006.04190.x). Journal of Gastroenterology and Hepatology (Australia). 2006 Dec;21(12):1871. https://doi.org/10.1111/j.1440-1746.2006.04760.x

Ariizumi, K. ; Ohara, S. ; Koike, T. ; Inomata, Y. ; Iijima, Katsunori ; Sekine, H. ; Noguchi, M. ; Sugiyama, K. ; Eda, Y. ; Kayaba, S. ; Kawamura, M. ; Shimosegawa, Toru. / Erratum : Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism (Journal of Gastroenterology and Hepatology DOI: 10.1111/j.1440-1746.2006.04190.x). In: Journal of Gastroenterology and Hepatology (Australia). 2006 ; Vol. 21, No. 12. pp. 1871.

@article{1d50d36a0ff34d5ea1af9d621bfc0362,

title = "Erratum: Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism (Journal of Gastroenterology and Hepatology DOI: 10.1111/j.1440-1746.2006.04190.x)",

author = "K. Ariizumi and S. Ohara and T. Koike and Y. Inomata and Katsunori Iijima and H. Sekine and M. Noguchi and K. Sugiyama and Y. Eda and S. Kayaba and M. Kawamura and Toru Shimosegawa",

year = "2006",

month = dec,

doi = "10.1111/j.1440-1746.2006.04760.x",

language = "English",

volume = "21",

pages = "1871",

journal = "Journal of Gastroenterology and Hepatology (Australia)",

issn = "0815-9319",

publisher = "Wiley-Blackwell",

number = "12",

}

TY - JOUR

T1 - Erratum

T2 - Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism (Journal of Gastroenterology and Hepatology DOI: 10.1111/j.1440-1746.2006.04190.x)

AU - Ariizumi, K.

AU - Ohara, S.

AU - Koike, T.

AU - Inomata, Y.

AU - Iijima, Katsunori

AU - Sekine, H.

AU - Noguchi, M.

AU - Sugiyama, K.

AU - Eda, Y.

AU - Kayaba, S.

AU - Kawamura, M.

AU - Shimosegawa, Toru

PY - 2006/12

Y1 - 2006/12

UR - http://www.scopus.com/inward/record.url?scp=33750432523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750432523&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1746.2006.04760.x

DO - 10.1111/j.1440-1746.2006.04760.x

M3 - Comment/debate

AN - SCOPUS:33750432523

VL - 21

SP - 1871

JO - Journal of Gastroenterology and Hepatology (Australia)

JF - Journal of Gastroenterology and Hepatology (Australia)

SN - 0815-9319

IS - 12

ER -

Erratum: Therapeutic effects of 10 mg/day rabeprazole administration on reflux esophagitis was not influenced by the CYP2C19 polymorphism (Journal of Gastroenterology and Hepatology DOI: 10.1111/j.1440-1746.2006.04190.x)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this